HanxBio H1 FY26 loss narrows to RMB 33.24 million; other income and gains more than doubled to RMB 27.61 millionPUBT·Aug 17 at 03:34 AM03378+3.18%
Hong Kong's Non-Consensus Corners: Crypto ETFs and Biotech Lead the ReboundGlobal Report·Aug 15 at 04:43 AM03378+3.18%09885+6.77%
Hanx Biopharmaceuticals sets board meeting to review interim resultsPUBT·Aug 5 at 03:41 AM03378+3.18%
The Un-Aggregated Economy: Supply Chain Realities in Hong Kong's Long Tail AssetsGlobal Report·Jul 25 at 04:13 AM02459+11.11%011110.00%
Hanx Biopharmaceuticals files HKEX next-day disclosure return on share repurchase cancellationPUBT·Jul 16 at 05:27 AM03378+3.18%
Hanx Biopharma files HKEX next-day disclosure return on share repurchasePUBT·Jul 15 at 06:33 AM03378+3.18%
Hanx Biopharmaceuticals files HKEX next-day disclosure after share repurchasePUBT·Jul 14 at 06:25 AM03378+3.18%
Hanx Biopharmaceuticals files HKEX next-day disclosure return on share repurchasePUBT·Jul 13 at 05:48 AM03378+3.18%
Can AI collaborations power China’s next wave of blockbuster drug deals?SCMP·Jul 13 at 05:33 AM01093-3.47%03378+3.18%
Hanx Biopharma files HKEX next-day return disclosing share buyback at HKD 28.96 eachPUBT·Jul 10 at 06:19 AM03378+3.18%
Hanx Biopharmaceuticals files HKEX next-day return disclosing share buyback at HKD 28.63 eachPUBT·Jul 9 at 04:58 AM03378+3.18%
Hanx Biopharmaceuticals files HKEX next-day disclosure return on share repurchase at HKD 28.91 avg pricePUBT·Jul 7 at 06:28 AM03378+3.18%
Hanx Biopharmaceuticals posts announcement on AI-driven drug discovery collaborationPUBT·Jul 7 at 05:54 AM03378+3.18%
Hanx Biopharmaceuticals files HKEX next-day disclosure return on share repurchase at HKD 28.68 avgPUBT·Jul 3 at 06:28 AM03378+3.18%
